- Report
- April 2025
- 175 Pages
Global
From €3915EUR$4,490USD£3,404GBP
- Report
- January 2026
- 181 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- January 2026
- 191 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1308EUR$1,500USD£1,137GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1090EUR$1,250USD£948GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1090EUR$1,250USD£948GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1308EUR$1,500USD£1,137GBP
- Report
- April 2025
- 182 Pages
Global
From €3923EUR$4,500USD£3,412GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1090EUR$1,250USD£948GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1308EUR$1,500USD£1,137GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1744EUR$2,000USD£1,516GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1744EUR$2,000USD£1,516GBP
- Report
- January 2026
- 180 Pages
Global
From €3923EUR$4,500USD£3,412GBP
- Report
- June 2025
- 150 Pages
Global
From €2353EUR$2,699USD£2,046GBP
- Report
- June 2025
- 200 Pages
Global
From €2432EUR$2,789USD£2,115GBP
- Report
- August 2025
- 150 Pages
Global
From €3357EUR$3,850USD£2,919GBP
€4229EUR$4,850USD£3,677GBP
- Report
- July 2025
- 150 Pages
Global
From €3357EUR$3,850USD£2,919GBP
€4229EUR$4,850USD£3,677GBP
- Report
- May 2025
- 134 Pages
Global
From €15690EUR$17,995USD£13,644GBP
- Report
- February 2026
- 50 Pages
Global
From €2311EUR$2,650USD£2,009GBP
- Report
- February 2026
- 50 Pages
Global
From €2311EUR$2,650USD£2,009GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more